Universal health coverage aims to provide access to essential healthcare services, including medicines and vaccines, for all individuals, regardless of their ability to pay. Therefore, it is not a barrier to access.

The TRIPS Agreement is an international agreement that sets minimum standards for the protection of intellectual property rights, including patents for medicines and vaccines.

Pneumonia is the leading cause of death among children under the age of five globally, accounting for approximately 15% of all deaths in this age group.

The Global Vaccine Alliance (Gavi) is a global health partnership that aims to increase access to vaccines in developing countries, with a focus on reaching the poorest and most vulnerable populations.

Price controls on medicines, voluntary licensing agreements, and technology transfer for local production are all strategies that have been used to improve access to medicines and vaccines in low- and middle-income countries.

The World Health Organization (WHO) estimates that approximately 30% of the world's population lacks access to essential medicines.

All of the above are challenges associated with the development of vaccines for neglected diseases.

The Global Fund to Fight AIDS, Tuberculosis and Malaria is a global fund that provides financial support for programs to fight HIV/AIDS, tuberculosis, and malaria.

All of the above are strategies to promote rational use of medicines.

Every Woman Every Child is a global health initiative that aims to eliminate preventable child deaths and improve maternal health.

All of the above are challenges associated with the distribution of vaccines in low-resource settings.

The Product Development Partnership (PDP) is a global health initiative that aims to accelerate the development and delivery of vaccines for neglected diseases.

All of the above are strategies to address the high cost of medicines.

Unitaid is a global health initiative that aims to improve access to essential medicines and vaccines for people living in poverty.

All of the above are challenges associated with the development of new vaccines.